K012567

Substantially Equivalent

MODIFICATION TO: REAADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KIT

Applicant
Corgenix, Inc.
Product code
MID
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Westminster, CO, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.